# Neostigmine Methylsulfate

NDC: 0641-6264
Generic name: Neostigmine Methylsulfate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20151228

FDA application: ANDA207042

## Active ingredients

- NEOSTIGMINE METHYLSULFATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0641-6264"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0641-6264
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28365ed5-8332-48ac-a93d-b165ac3c6eac